Status:
COMPLETED
Sensorimotor Training Using Whole Body Vibration Exercise to Reduce Chemotherapy-induced Peripheral Neuropathy
Lead Sponsor:
Karolinska Institutet
Conditions:
Breast Neoplasm, Exercise
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
CIPN is induced by neurotoxic chemotherapeutic agents and manifests with sensory and/or motor deficits. It is associated with significant disability and poor recovery. Common symptoms include pain, al...
Detailed Description
Aim: To (a) compare the effects of WBV exercise compared to regular cardiovascular and resistance exercise (CAR) on the primary outcome of (a) CIPN symptoms and secondary outcomes of (b) balance, phys...
Eligibility Criteria
Inclusion
- patients with breast cancer, aged 18-80 years,
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-2,
- completed chemotherapy in the past 3 months. Experiencing symptoms of CIPN
Exclusion
- pre-existing neuropathy of other cause (eg, diabetes),
- given contraindications for WBV including instable bone metastases and severe cardiovascular disease.
Key Trial Info
Start Date :
October 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2024
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05361018
Start Date
October 17 2022
End Date
October 30 2024
Last Update
November 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital
Stockholm, Sweden, 11447